Purple Biotech reported net income of -$0.44M for the quarter ended Jun 2026. This income statement covers 36 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2014 | Dec2014 | Sep2015 | Dec2015 | Jun2016 | Dec2016 | Jun2017 | Dec2017 | Jun2018 | Dec2018 | Jun2019 | Dec2019 | Jun2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.09M | 0.09M | 0.13M | 0.16M | ||||||||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 1.62M | 4.87M | 5.95M | 2.08M | 3.46M | 4.82M | 3.50M | 3.71M | 4.59M | 5.24M | 3.42M | 2.39M | 1.35M | 0.46M | 0.76M | 0.55M | 0.59M | 1.83M | 1.23M | 0.70M | ||||||||||||||||
| Selling, General & AdministrativeSG&A | 1.42M | 2.91M | 1.38M | 1.51M | 1.62M | 1.78M | 1.62M | 1.43M | 1.16M | 1.02M | 1.04M | 0.86M | 0.79M | 0.56M | 0.65M | 0.68M | 0.78M | 1.14M | 1.02M | 0.60M | ||||||||||||||||
| Other Operating ExpensesOther Opex | 0.20M | 20.48M | ||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 3.04M | 7.78M | 7.33M | 3.59M | 5.08M | 6.60M | 5.12M | 5.13M | 5.75M | 6.27M | 4.47M | 3.46M | 2.13M | 1.02M | 1.41M | 1.24M | 1.37M | 23.45M | 2.25M | 1.30M | ||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.02M | 0.09M | 0.04M | 0.05M | 0.02M | 0.02M | 0.06M | 0.15M | 0.02M | 2.09M | 0.02M | 0.02M | 0.51M | -0.07M | 0.04M | -0.02M | 0.01M | 0.21M | 0.03M | 0.01M | ||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | -0.07M | -0.12M | -0.06M | -0.09M | -0.25M | -0.58M | -0.28M | -0.12M | -0.71M | -1.41M | -0.10M | -0.12M | -0.13M | -0.46M | -0.05M | -0.07M | -0.12M | -0.08M | -0.02M | -0.08M | ||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.01M | -0.02M | -0.22M | -0.69M | -3.50M | -0.69M | -0.95M | -1.47M | -0.08M | -0.95M | -0.07M | -0.06M | 0.06M | -2.16M | -1.67M | |||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.05M | -0.03M | -0.04M | -0.23M | -0.56M | 0.03M | -0.69M | -1.41M | -1.04M | -0.15M | ||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||
| Profit After TaxPAT | 3.15M | -7.75M | 7.32M | 3.55M | 4.85M | 6.04M | 4.90M | 5.16M | 5.05M | 4.86M | 3.78M | 2.42M | 0.67M | 0.41M | 0.46M | 1.09M | 1.30M | 23.64M | 0.09M | -0.44M | ||||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | 0.01M | 0.05M | 0.02M | 0.02M | 0.03M | 0.03M | 0.03M | 0.02M | 0.02M | 0.03M | 0.02M | 0.01M | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M | 0.10M | 0.00M | |||||||||||||||||
| Income from Discontinued OperationsIncome (Discontinued) | 0.15M | 0.51M | ||||||||||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | 0.15M | 0.51M | ||||||||||||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | 3.14M | 8.21M | 7.30M | 3.54M | 4.82M | 6.01M | 4.88M | 5.14M | 5.04M | 4.83M | 3.76M | 2.40M | 0.66M | 0.41M | 0.45M | 1.08M | 1.30M | 23.55M | 0.09M | -0.44M | ||||||||||||||||
| Net Income towards Common StockholdersNet Income | 3.14M | 8.21M | 7.30M | 3.54M | 4.82M | 6.01M | 4.88M | 5.14M | 5.04M | 4.83M | 3.76M | 2.40M | 0.66M | 0.41M | 0.45M | 1.08M | 1.30M | 23.55M | 0.09M | -0.44M | ||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||
| EPS (Basic) | 54.56 | 93.45 | 83.07 | 40.26 | 54.92 | 66.49 | 53.96 | 56.83 | 55.70 | 43.63 | 33.99 | 21.73 | 5.99 | 2.50 | 2.76 | 6.62 | 7.95 | 143.61 | 0.52 | -2.69 | ||||||||||||||||
| EPS (Diluted) | 54.56 | 93.45 | 83.07 | 40.26 | 54.92 | 66.49 | 53.96 | 56.83 | 55.70 | 43.63 | 33.99 | 21.73 | 5.99 | 2.50 | 2.76 | 6.62 | 7.95 | 49.05 | 0.18 | -0.92 | ||||||||||||||||
| Shares Outstanding | 0.06M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M | 0.11M | 0.11M | 0.11M | 0.11M | 0.16M | 0.16M | 0.16M | 0.16M | 0.16M | 0.16M | 0.16M | ||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.06M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M | 0.09M | 0.11M | 0.11M | 0.11M | 0.11M | 0.16M | 0.16M | 0.16M | 0.16M | 0.48M | 0.48M | 0.48M | ||||||||||||||||
| Interest ExpensesInt Expense | 0.02M | 0.09M | 0.04M | 0.05M | 0.02M | 0.02M | 0.06M | 0.15M | 0.02M | 2.09M | 0.02M | 0.02M | 0.51M | -0.07M | 0.04M | -0.02M | 0.01M | 0.21M | 0.03M | 0.01M |